Sumitomo Mitsui Trust Holdings, Inc. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 313 filers reported holding NOVOCURE LTD in Q4 2022. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sumitomo Mitsui Trust Holdings, Inc. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2023$9,646,053
-40.2%
232,435
-13.3%
0.01%
-33.3%
Q1 2023$16,118,422
-17.6%
268,015
+0.5%
0.01%
-20.0%
Q4 2022$19,558,337
-4.7%
266,644
-1.3%
0.02%
-11.8%
Q3 2022$20,532,000
+10.7%
270,225
+1.3%
0.02%
+21.4%
Q2 2022$18,541,000
-13.2%
266,777
+3.5%
0.01%0.0%
Q1 2022$21,362,000257,8440.01%
Other shareholders
NOVOCURE LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders